Cargando…
Graded Defects in Cytotoxicity Determine Severity of Hemophagocytic Lymphohistiocytosis in Humans and Mice
Primary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease of hyperinflammation resulting from immune dysregulation due to inherited defects in the cytolytic machinery of natural killer and T cells. In humans, mutations in seven genes encoding proteins involved in cytolytic effec...
Autores principales: | Jessen, Birthe, Kögl, Tamara, Sepulveda, Fernando E., de Saint Basile, Genevieve, Aichele, Peter, Ehl, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864253/ https://www.ncbi.nlm.nih.gov/pubmed/24379813 http://dx.doi.org/10.3389/fimmu.2013.00448 |
Ejemplares similares
-
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)
por: Weißert, Kristoffer, et al.
Publicado: (2022) -
Cell Versus Cytokine – Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity
por: Wegehaupt, Oliver, et al.
Publicado: (2020) -
Approaching hemophagocytic lymphohistiocytosis
por: Chinnici, Aurora, et al.
Publicado: (2023) -
T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations
por: Ghosh, Sujal, et al.
Publicado: (2018) -
Late‐onset hemophagocytic lymphohistiocytosis with neurological presentation
por: Benezech, Sarah, et al.
Publicado: (2017)